CytoDyn Alerts Shareholders to Vote on Company’s
Post# of 148263
(Total Views: 606)
Posted On: 10/18/2021 7:07:01 AM
CytoDyn Alerts Shareholders to Vote on Company’s Proxy Card Ahead of October 28th Annual Meeting
VANCOUVER, Wash.--(BUSINESS WIRE)-- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that shareholders will receive proxy material beginning this week from the Company in connection with its upcoming 2021 Annual Meeting of Stockholders on October 28, 2021 (the “Annual Meeting”).
The Company urges all shareholders to vote their shares immediately on the Company’s card upon receipt of the proxy material to ensure their votes count in time for the Annual Meeting. Shareholders should expect to be contacted by the Company’s proxy solicitor, Morrow Sodali, to provide personalized assistance for voting.
As a reminder, the Delaware Court of Chancery found that CytoDyn’s Board of Directors properly rejected a nomination notice presented by the activist group. In light of the Court ruling on October 13th, the Company will disregard the group’s director nominations, and no proxies or votes in favor of its nominees will be recognized or tabulated at the 2021 Annual Meeting, absent judicial intervention requiring otherwise.
Shareholders of record as of September 1, 2021, are entitled to vote at the Annual Meeting.
https://www.cytodyn.com/newsroom/press-releas...anys-proxy
VANCOUVER, Wash.--(BUSINESS WIRE)-- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that shareholders will receive proxy material beginning this week from the Company in connection with its upcoming 2021 Annual Meeting of Stockholders on October 28, 2021 (the “Annual Meeting”).
The Company urges all shareholders to vote their shares immediately on the Company’s card upon receipt of the proxy material to ensure their votes count in time for the Annual Meeting. Shareholders should expect to be contacted by the Company’s proxy solicitor, Morrow Sodali, to provide personalized assistance for voting.
As a reminder, the Delaware Court of Chancery found that CytoDyn’s Board of Directors properly rejected a nomination notice presented by the activist group. In light of the Court ruling on October 13th, the Company will disregard the group’s director nominations, and no proxies or votes in favor of its nominees will be recognized or tabulated at the 2021 Annual Meeting, absent judicial intervention requiring otherwise.
Shareholders of record as of September 1, 2021, are entitled to vote at the Annual Meeting.
https://www.cytodyn.com/newsroom/press-releas...anys-proxy
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
My comments are just my opinions and should NOT be taken as investment advice.
Scroll down for more posts ▼